Saturday, November 21, 2009
You are here: Topics > Environment > Genetic Modification > Research Release Applications
Application for a Part B Consent from MedImmune LLC to evaluate MEDI-534 as a vaccine against Respiratory Syncytial Virus and Parainfluenza Virus Type 3 in small children.
This Part B was granted in March 2009.
Page updated: Monday, August 3, 2009